Bill

Bill > HR2592


US HR2592

US HR2592
Aviation Medication Transparency Act of 2025


summary

Introduced
04/02/2025
In Committee
04/02/2025
Crossed Over
Passed
Dead

Introduced Session

119th Congress

Bill Summary

A BILL To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen, and for other purposes.

AI Summary

This bill requires the Federal Aviation Administration (FAA) Administrator to publish and maintain a comprehensive, user-friendly list of medications and treatments that can be safely prescribed to airmen for medical certification purposes within one year of the bill's enactment. The list must be developed through consultation with key stakeholders, including the Aeromedical Innovation and Modernization Working Group, air traffic controllers' representatives, airline pilots' collective bargaining representatives, and other relevant stakeholders. The published list will include detailed information such as: medications designated as "Do Not Issue", average periods of time airmen might need limited duties while stabilizing on approved medications, a contact mechanism for medical providers to ask questions, and explanations for why certain medications are allowed or prohibited. The FAA Administrator is required to update this list annually, ensuring it remains current and provides clear guidance for airmen seeking medical certification. This legislation aims to increase transparency and provide clear medical guidelines for aviation professionals, ultimately supporting both safety and professional clarity in the aviation industry.

Committee Categories

Transportation and Infrastructure

Sponsors (6)

Last Action

Referred to the House Committee on Transportation and Infrastructure. (on 04/02/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...